iodide/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
iodide — decreases intensive care unit length of stay
Evidence strength: moderate.Finding“In which the patients that received iodine (8.33 days S.D. 5.5, n = 7) had a significantly shorter stay on the ICU compared to the standard of care group (26.5 days S.D. 19, n = 11) (Fig 2).”
Quoted verbatim from Iodine increases pulmonary type I interferon responses and decreases covid-19 disease severity: Results from an open label randomized clinical trial.. - Study
- RCT
- Duration
- 8 days
- Dose
- 12.5 mg iodine as potassium iodide tablets once daily for 8 days
- Population
- Adults hospitalised with PCR-confirmed COVID-19 in a Dutch community hospital, all on standard care; only the subset who were admitted to the ICU (7 iodine, 11 control), analysed after randomisation; open-label, no placebo
Iodine increases pulmonary type I interferon responses and decreases covid-19 disease severity: Results from an open label randomized clinical trial.2026PMID:4162812610.1371/journal.pone.0341126Permalink
To cite this finding: https://catalystproject.ai/e/01M5NFFPJWQBV864YNAME410CQ